Chien‐Hung Chen

8.2k citations

233 papers · 5.6k indexed · h-index 41

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 202
- Hepatitis C virus research 151
- Hepatocellular Carcinoma Treatment and Prognosis 50
- Liver Disease and Transplantation 25
- Hepatitis Viruses Studies and Epidemiology 9
Epidemiology 202
- Liver Disease Diagnosis and Treatment 158
- Hepatitis B Virus Studies 146

Co-authors: Jing‐Houng Wang Tsung‐Hui Hu Sheng‐Nan Lu Chuan–Mo Lee Chao‐Hung Hung Chi‐Sin Changchien Jin‐Chuan Sheu Kwong‐Ming Kee
Journals: Journal of Gastroenterology and Hepatology (16 papers)PLoS ONE (15 papers)Liver International (12 papers)Journal of Hepatology (12 papers)Hepatology International (10 papers)
Partner nations: Taiwan United States Germany

In The Last Decade

Chien‐Hung Chen

227 papers receiving 5.5k citations

Peers

Countries citing papers authored by Chien‐Hung Chen

Since Specialization

Citations

This map shows the geographic impact of Chien‐Hung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Hung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Hung Chen more than expected).

Fields of papers citing papers by Chien‐Hung Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Hung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Hung Chen. The network helps show where Chien‐Hung Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Chien‐Hung Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chien‐Hung Chen Line = papers co-authored together Chien‐Hung Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survival outcome with liver resection versus percutaneous radiofrequency ablation in patients with 2–3 cm single hepatocellular carcinoma Asian Journal of Surgery ·Yi‐Hao Yen, Yueh-Wei Liu, Sheng‐Nan Lu, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen, Kwong‐Ming Kee, Chee‐Chien Yong, Weifeng Li, Chih‐Chi Wang, Chih-Yun Lin	2025	0
2	Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinoma Langenbeck s Archives of Surgery ·S. Chung, Chee‐Chien Yong, Kwong‐Ming Kee, Sheng‐Nan Lu, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen, Yueh-Wei Liu, Weifeng Li, Chih‐Chi Wang, Yi-Hao Yen, Chih-Yun Lin	2025	1
3	Clinical outcomes and predictors in patients with acute on chronic liver failure in Southern Taiwan Journal of the Formosan Medical Association ·Pao‐Yuan Huang, Yu‐Cheng Lin, Chih‐Chi Wang, Chien‐Hung Chen	2024	0
4	Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib The Kaohsiung Journal of Medical Sciences ·Ya‐Wen Hsiao, Fai‐Meng Sou, Jing‐Houng Wang, Yen‐Hao Chen, Ming‐Chao Tsai, Tsung‐Hui Hu, Chao‐Hung Hung, Chien‐Hung Chen, Yuan‐Hung Kuo	2023	1
5	Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation Diagnostics ·Chih‐Chien Yao, Jing‐Houng Wang, Chien‐Hung Chen, Chao‐Hung Hung, Yi‐Hao Yen, Kwong‐Ming Kee, Tsung‐Hui Hu, Ming‐Chao Tsai, Yuan‐Hung Kuo, Sheng‐Nan Lu	2023	2
6	Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation Journal of Antimicrobial Chemotherapy ·Tzu‐Ning Tseng, Wen‐Juei Jeng, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Sheng‐Nan Lu, Chien‐Hung Chen	2022	2
7	On-site Ultrasound Screens out Asymptomatic Knee Lesions in Elite Adolescent Male Basketball Players International Journal of Medical Sciences ·Chan-Shien Ho, Tung‐Yang Yu, Chien‐Hung Chen, Yin‐Chou Lin, Wen‐Chung Tsai	2022	2
8	Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias PLoS ONE ·Yi‐Hao Yen, Yu‐Fan Cheng, Jing‐Houng Wang, Chih‐Che Lin, Chien‐Hung Chen, Chih‐Chi Wang	2021	12
9	Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan Nutrients ·Ming‐Chao Tsai, Yu-Yin Liu, Chih‐Che Lin, Chih‐Chi Wang, Yi‐Ju Wu, Chee-Chien Yong, Kuang‐Den Chen, Seng‐Kee Chuah, Chih‐Chien Yao, Pao‐Yuan Huang, Chien‐Hung Chen, Tsung‐Hui Hu, Chao‐Long Chen	2020	70
10	Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan Alimentary Pharmacology & Therapeutics ·Tsung‐Hui Hu, Sherry Yueh‐Hsia Chiu, Po‐Lin Tseng, Chien‐Hung Chen, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Kwong‐Ming Kee, Ming‐Tsung Lin, Kuo‐Chin Chang, Meng‐Chih Lin, Rong‐Nan Chien	2020	14
11	Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy Journal of Clinical Medicine ·Pao‐Yuan Huang, Chih‐Chi Wang, Chih‐Che Lin, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Kwong‐Ming Kee, Chien‐Hung Chen, Kuang‐Den Chen, Tsung‐Hui Hu, Ming‐Chao Tsai	2019	24
12	Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis Scientific Reports ·Chun‐Hsien Chen, Chien‐Hung Chen, Chih‐Lang Lin, Chun‐Yen Lin, Tsung‐Hui Hu, Shui‐Yi Tung, Sen‐Yung Hsieh, Sheng‐Nan Lu, Rong‐Nan Chien, Chao‐Hung Hung, I‐Shyan Sheen	2019	9
13	Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment PLoS ONE ·Te‐Ling Ma, Tsung‐Hui Hu, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu, Chien‐Hung Chen	2019	27
14	Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients Digestive and Liver Disease ·Yi‐Hao Yen, Fang‐Ying Kuo, Kwong‐Ming Kee, Kuo‐Chin Chang, Ming‐Chao Tsai, Tsung‐Hui Hu, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen	2018	2
15	The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients Liver International ·Yi‐Hao Yen, Ming‐Tsung Lin, Fang‐Ying Kuo, Kuo‐Chin Chang, Ming‐Chao Tsai, Po‐Lin Tseng, Cheng‐Kun Wu, J.C. Lin, Tsung‐Hui Hu, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen	2017	14
16	Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion Scandinavian Journal of Gastroenterology ·Yuan‐Hung Kuo, Chien‐Hung Chen, Jing‐Houng Wang, Chou-Hung Hung, Po‐Lin Tseng, Sheng‐Nan Lu, Chi‐Sin Changchien, Chuan–Mo Lee	2009	31
17	Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma Journal of Viral Hepatitis ·Chien‐Hui Hung, Chien‐Hung Chen, C.‐M. Lee, Cheng‐Kun Wu, Tsung‐Hui Hu, J.‐H. Wang, Yi‐Hao Yen, Sheng‐Nan Lu	2007	23
18	Study of hepatitis B (HB) vaccine non‐responsiveness among health care workers from an endemic area (Taiwan) Liver International ·Yi‐Hao Yen, Chien‐Hung Chen, Jing‐Houng Wang, Chuan‐Mo Lee, Chi‐Sin Changchien, Sheng‐Nan Lu	2005	43
19	Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants Journal of Hepatology ·Chien‐Hung Chen, Chuan–Mo Lee, Sheng‐Nan Lu, Jing‐Houng Wang, Hung‐Da Tung, Chao‐Hung Hung, Wei J. Chen, Chi‐Sin Changchien	2004	41
20	CASE REPORT: Lamivudine Treatment for Recurrent Pancreatitis Associated with Reactivation of Chronic B Hepatitis Digestive Diseases and Sciences ·Chien‐Hung Chen, Chi‐Sin Changchien, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Chuan–Mo Lee	2002	5

About Chien‐Hung Chen

Chien‐Hung Chen is a scholar working on Hepatology, Epidemiology, Cancer Research, Infectious Diseases and Oncology, having authored 233 papers that have together received 5.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (158 papers), Hepatitis C virus research (151 papers), Hepatitis B Virus Studies (146 papers), Hepatocellular Carcinoma Treatment and Prognosis (50 papers), Liver Disease and Transplantation (25 papers), HIV/AIDS drug development and treatment (10 papers), Hepatitis Viruses Studies and Epidemiology (9 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Hepatology (4.2k citations), Epidemiology (4.4k citations), Cancer Research (318 citations), Infectious Diseases (376 citations) and Oncology (390 citations). Chien‐Hung Chen has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Jing‐Houng Wang, Tsung‐Hui Hu, Sheng‐Nan Lu, Chuan–Mo Lee, Chao‐Hung Hung, Chi‐Sin Changchien, Chao‐Hung Hung, Jin‐Chuan Sheu, Kwong‐Ming Kee and Yi‐Hao Yen. Their work appears in journals such as Journal of Gastroenterology and Hepatology, PLoS ONE, Liver International, Journal of Hepatology and Hepatology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact